OKI-179
Phase 1Completed 1 views this week 0 watching💤 Quiet
Interest: 19/100
19
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Advanced Solid Tumors
Conditions
Advanced Solid Tumors
Trial Timeline
May 8, 2019 → Nov 27, 2021
NCT ID
NCT03931681About OKI-179
OKI-179 is a phase 1 stage product being developed by OnKure Therapeutics for Advanced Solid Tumors. The current trial status is completed. This product is registered under clinical trial identifier NCT03931681. Target conditions include Advanced Solid Tumors.
What happened to similar drugs?
16 of 20 similar drugs in Advanced Solid Tumors were approved
Approved (16) Terminated (1) Active (4)
Hype Score Breakdown
Clinical
6
Activity
8
Company
5
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03931681 | Phase 1 | Completed |
Competing Products
20 competing products in Advanced Solid Tumors